Open-label treatment with olanzapine for patients with borderline personality disorder

Mary C. Zanarini, S. Charles Schulz, Holland Detke, Fangyi Zhao, Daniel Lin, Mary Pritchard, Walter Deberdt, Garrett Fitzmaurice, Sara Corya

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Open-label treatment with olanzapine for patients with borderline personality disorder'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience